PDCD1LG2 and neoplasm: Particularly, anti-PD-1 antibodies showed dramatic anti-tumor responses in classical Hodgkin lymphoma (HL) [54,55], which is characterized by chromosome 9p24.1 alterations, including polysomy, copy gain and amplification, and resulting in enhanced PD-L1/PD-L2 expression [56].